We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 20

Medical diagnostic claims and Bilski
  • Gowling WLG
  • USA
  • September 6 2010

In the long awaited decision in Bilski v. Kappos, the U.S. Supreme Court has concluded that the machine-or-transformation (“MOT”) test is not the sole arbiter of patentable subject matter for “processes” under section 101 of the U.S. Patent Act.


Medical diagnostic claims and Bilski
  • Gowling WLG
  • USA
  • July 9 2010

In the long awaited decision in Bilski v. Kappos, the U.S. Supreme Court has concluded that the machine-or-transformation (“MOT”) test is not the sole arbiter of patentable subject matter for “processes” under section 101 of the U.S. Patent Act.


Pfizer v Apotex; decision on the merits of a 55.2 proceeding; January 4, 2008; drug: atorvastatin
  • Gowling WLG
  • USA
  • February 7 2008

The Trial Division found the patent at issue to be invalid as it did not meet the test for a valid selection, and it claimed subject matter that was already the subject of a previous patent.


Isabel Raasch
  • Gowling WLG

Scott E. Foster
  • Gowling WLG

Hélène D'Iorio
  • Gowling WLG

Alex Gloor
  • Gowling WLG



Patrick Duxbury
  • Gowling WLG